Christoffer Rasmus Vissing

Medicin og biovidenskab

1. Exercise 100%
2. Muscles 97%
3. Facioscapulohumeral Muscular Dystrophy 89%
4. Fats 71%
5. Mitochondrial DNA 70%
6. Paraspinal Muscles 60%
7. Limb-Girdle Muscular Dystrophies 57%
8. acylcarnitine 54%
9. Skeletal Muscle 51%
10. Glycogen Storage Disease Type V 50%
11. Myoglobinuria 46%
12. Recurrent Myoglobinuria 43%
13. Mutation 42%
14. Glycogen Storage Disease XIV 40%
15. Mitochondrial Myopathies 40%
16. Muscular Diseases 36%
17. Cardiac Arrhythmias 36%
18. Bethlem myopathy 35%
19. Anoctamins 34%
20. Glycogen Storage Disease Type III 33%
21. Randomized Controlled Trials 32%
22. mirabegron 32%
23. Limb-girdle muscular dystrophy type 2A 32%
24. Stroke Volume 30%
25. Heart Failure 29%
26. Muscular Dystrophy, Limb-Girdle, Type 2M 29%
27. Myotonia Congenita 28%
28. Glycogen Storage Disease Type II 27%
29. Connectin 27%
30. Coronavirus Infections 27%
31. Glycogen Storage Disease 27%
32. Muscle Strength 27%
33. Arrhythmogenic Right Ventricular Dysplasia 27%
34. Muscular Dystrophy, Limb-Girdle, Type 2L 26%
35. Cardiomyopathies 26%
36. Left Ventricular Dysfunction 25%
37. Severe Acute Respiratory Syndrome 24%
38. Out-of-Hospital Cardiac Arrest 24%
39. Maternal Inheritance 24%
40. Genes 24%
41. Healthy Aging 24%
42. Leg 23%
43. Defibrillators 23%
44. Creatine Kinase 23%
45. Duchenne Muscular Dystrophy 22%
46. Physical Fitness 22%
47. Cyclic GMP 22%
48. Dilated Cardiomyopathy 22%
49. Glycogen 22%
50. Chronic Progressive External Ophthalmoplegia 22%